Abiopharma

🔍 Goldstein Lainie (Director)

Company: Phreesia, Inc. (PHR)

Report Date: 2026-07-31

Detailed Transactions and Holdings:

• Acquired 377 shares of Common Stock at $10.73 per share (Direct)
  Date: 2026-07-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 70,862.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Granted as a result of director's election to receive deferred stock units ("DSUs") in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. The DSUs are awarded on the date such annual cash retainer would otherwise be payable (i.e., quarterly in arrears). Director shall receive underlying common stock 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.